Participant perceived understanding and perspectives toward pharmacogenomics: Mayo Clinic Right Drug, Right Dose, Right Time (RIGHT) Protocol

PURPOSE: To examine predictors of understanding preemptive CYP2D6 pharmacogenomic test results and to identify key features required to improve future educational efforts of preemptive pharmacogenomic testing. METHODS: 1010 participants were surveyed after receiving preemptive CYP2D6 pharmacogenomic...

Descripción completa

Detalles Bibliográficos
Autores principales: Olson, Janet E., Rohrer Vitek, Carolyn R., Bell, Elizabeth J., McGree, Michaela E., Jacobson, Debra J., St. Sauver, Jennifer L., Caraballo, Pedro J., Griffin, Joan M., Roger, Veronique L., Bielinski, Suzette J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498279/
https://www.ncbi.nlm.nih.gov/pubmed/28055020
http://dx.doi.org/10.1038/gim.2016.192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498279/
https://www.ncbi.nlm.nih.gov/pubmed/28055020
http://dx.doi.org/10.1038/gim.2016.192

Ejemplares similares